fb-pixel Skip to main content

COVID-19 vaccine news, resources, and guidance

The latest on how and where to get a vaccine, plus the latest news and resources on development and distribution in Massachusetts

Who is currently eligible to receive a COVID-19 vaccine?

Here's who is currently eligible and when remaining groups will become eligible:
Health care workers and first respondersResidents 55+ and residents with one or more certain medical conditionsCompanions accompanying older residents to vaccination appointmentsK-12 teachers and school staffApril 19: The general public ages 16 and older will be eligible
A woman received the COVID-19 vaccine at a drive-through public health vaccination site in California.

How to find a vaccination location and schedule an appointment

The registration process includes finding a location, booking an appointment, and filling out a self-attestation form. Be sure to bring any identification that locations might request.
Click here for step-by-step instructions
The Twitter account Vaccinetime keeps track of open appointments by location in the state.

Tracking vaccine distribution in Massachusetts

Updated weekly.
Coronavirus or Flu virus - Microbiology And Virology Concept

SEE ALL CORONAVIRUS COVERAGE ⟶

The Globe is providing coverage of the coronavirus outbreak to keep you informed on the virus, track the latest developments on its spread, and educate you on how you can remain safe during this period.

COVID news and resources for Rhode Islanders

How to get vaccinated, the latest numbers, and more on the coronavirus's impact on the Ocean State.

Latest vaccine stories

Vials of Johnson & Johnson COVID-19 vaccine.

CDC advisers seek more data on rare clots before deciding next steps on Johnson & Johnson COVID-19 vaccine

Johnson & Johnson’s COVID-19 vaccine will remain in limbo a while longer after US health advisers told the government Wednesday that they need more evidence to decide if a handful of unusual blood clots were linked to the shot — and if so, how big the potential risk really is.
Patrick Andreottola, 101, got a shot late last month at his home from a Medford public health nurse.

2,004 confirmed cases, 14 deaths, and 92,459 vaccinations: See today’s new COVID-19 data from Mass.

The state said 35,786 people were estimated to have active cases of the potentially deadly virus, and 711 confirmed coronavirus patients were in the hospital.

Charts: Who has been vaccinated in Massachusetts, and how many doses has the state received?

The charts break down vaccination recipients by age, vaccination date, location, and race/ethnicity, while also outlining vaccination brand and administration site type.
Illustration of COVID-19 vaccine syringes surrounding cutout of Massachusetts state
Vaccination tracker

Here’s the latest on who has been vaccinated in Massachusetts

Distribution charts

How many vaccine doses Mass. has received, and who has been vaccinated

Development news

The latest on COVID-19 vaccine frontrunners

Mass. coronavirus at a glance |
Vaccinations
Daily doses:
Weekly doses:
1+ dose received:
Fully vaccinated:
% of doses used:
7-day trend/avg.:
Cases and deaths
Cases
.
Deaths
.
Other resources:
SOURCE: Mass. Dept. of Public Health

Latest COVID-19 vaccine stories

Governor Charlie Baker bumped elbows with Sam Kennedy, president and CEO of the Boston Red Sox, following a COVID-19 vaccination update at the Hynes Convention Center on Wednesday.

Baker announces ‘Red Sox Week’ at Hynes vaccination site to encourage vaccination among hard-hit groups

Next week at Hynes, 20,000 first-dose slots will be reserved for those disproportionately impacted by COVID, Governor Charlie Baker said. There will also be Red Sox-themed attractions, including socially distanced visits with Wally the Green Monster and a raffle to win tickets to a Red Sox game.

A box with vials of AstraZeneca vaccine against COVID-19 was taken out of a fridge.

Denmark decides not to resume use of AstraZeneca COVID-19 vaccine following reports of rare blood clots

Denmark decides not to resume use of AstraZeneca COVID-19 vaccine following reports of rare blood clots.

Dr. Anthony Fauci, Director at the National Institute Of Allergy and Infectious Diseases.

Fauci says Johnson & Johnson vaccine review will take ‘days to weeks’

The examination into the safety of the Johnson & Johnson COVID-19 vaccine that has paused the use of the single-shot treatment is not going to be “something that's going to drag out,” Dr. Anthony Fauci said Wednesday, predicting a decision “pretty quickly.”

Navy medical personnel from Virginia took buses up to Boston on orders from FEMA to give the COVID vaccinations to the thousands of people at the Hynes Convention Center.

The White House is speeding up its vaccination drive and pressuring states to follow its lead

Biden administration officials have been steadily boosting their direct supplies of vaccine to residents in Massachusetts and elsewhere through mass vaccination sites, retail pharmacies, and community health centers.

National Institute of Allergy and Infectious Diseases Director Anthony Fauci talked with reporters at the White House on April 13.

Why Biden health officials decided to pause J&J’s coronavirus vaccine

Their goal was to protect the public and be transparent, but critics worry they overreacted and might undermine vaccine confidence.

Johnson & Johnson Janssen Covid-19 vaccines at a vaccination center at the Miami Dade College North Campus in North Miami, Fla.

Here’s what to know about Johnson & Johnson COVID vaccines being paused

Medical experts say that if you received a dose of Johnson & Johnson vaccine within the past two weeks, don't worry and rest assured: the symptoms of a blood clot are not subtle.

Scott McIsaac gets vaccinated by nursing student Danelly Pimentel in Lowell.

1,401 confirmed cases, 7 deaths, and 90,144 vaccinations: See today’s new COVID-19 data from Mass.

The DPH said 35,857 people were estimated to have active cases of the potentially deadly virus, and 714 confirmed coronavirus patients were in the hospital.

Doses of the J&J vaccine.

J&J delays vaccine rollout in Europe amid blood clot fears in US

Johnson & Johnson said Tuesday it is delaying the rollout of its coronavirus vaccine in Europe amid a US probe into reports of rare blood clots in some recipients, moves that experts worry could further shake vaccine confidence and complicate COVID-19 immunization efforts.